Xinbang Pharmaceuticals: Report for the third quarter of 2024

SZSIOct 30 12:00 ET · Announcements

Guizhou Xinbang Pharmaceutical (002390.SZ) released its performance for the first three quarters, with a net income of 0.177 billion yuan, a year-on-year decrease of 28.38%.

Guizhou Xinbang Pharmaceutical (002390.SZ) released its third quarter report for 2024. In the first three quarters, the company achieved revenue...

Zhitong FinanceOct 30 05:01 ET

Guizhou Xinbang Pharmaceutical (SZSE:002390) Earnings and Shareholder Returns Have Been Trending Downwards for the Last Three Years, but the Stock Increases 7.7% This Past Week

Simply Wall StOct 28 22:31 ET

Does Guizhou Xinbang Pharmaceutical (SZSE:002390) Have A Healthy Balance Sheet?

Simply Wall StOct 2 21:23 ET

Guizhou Xinbang Pharmaceutical (002390.SZ): Its hospital offers testing services such as lymphocyte subgroups, lymphocyte activation, dendritic cells, cell apoptosis, and leukemia immune analysis.

Guizhou Xinbang Pharmaceutical (002390.SZ) stated on the investor interaction platform that its hospitals have testing services for lymphocyte subsets, lymphocyte activation, dendritic cells, cell apoptosis, and leukemia immunological analysis.

Gelonghui FinanceSep 20 03:45 ET

Guizhou Xinbang Pharmaceutical (002390.SZ): The produced Yixin Shu Capsule, Maixue Kang Capsule, silver ginkgo biloba leaves, and Dengzhanhua Drip are suitable for the middle-aged and elderly population.

On September 19, Guizhou Xinbang Pharmaceutical (002390.SZ) stated on the investor interaction platform that the company's produced Yixinshu capsules, Maixuekang capsules, ginkgo biloba leaves, and dandelion drops are suitable for the middle-aged and elderly population. As the leading pharmaceutical circulation company in Guizhou Province, the company has formed a comprehensive distribution system that includes both pharmaceuticals and medical devices. The pharmaceuticals sold by the company's subsidiary pharmaceutical distribution company include the category you are interested in. Currently, Guizhou Medical University affiliated Baiyun Hospital, under the company, has set up sanatoriums in the department of general practice medicine, providing professional treatment and care for elderly patients.

Gelonghui FinanceSep 19 05:36 ET